Connor, Clark & Lunn Investment Management (CC&L)’s Teladoc Health TDOC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.2M | Sell |
1,510,823
-47,546
| -3% | -$414K | 0.05% | 334 |
|
2025
Q1 | $12.4M | Buy |
1,558,369
+200,494
| +15% | +$1.6M | 0.05% | 279 |
|
2024
Q4 | $12.3M | Sell |
1,357,875
-343,286
| -20% | -$3.12M | 0.06% | 271 |
|
2024
Q3 | $15.6M | Buy |
1,701,161
+228,004
| +15% | +$2.09M | 0.08% | 197 |
|
2024
Q2 | $14.4M | Buy |
1,473,157
+154,982
| +12% | +$1.52M | 0.06% | 231 |
|
2024
Q1 | $19.9M | Buy |
1,318,175
+681,496
| +107% | +$10.3M | 0.09% | 205 |
|
2023
Q4 | $13.7M | Sell |
636,679
-21,756
| -3% | -$469K | 0.06% | 237 |
|
2023
Q3 | $12.2M | Buy |
658,435
+57,989
| +10% | +$1.08M | 0.06% | 232 |
|
2023
Q2 | $15.2M | Sell |
600,446
-74,290
| -11% | -$1.88M | 0.08% | 195 |
|
2023
Q1 | $17.5M | Sell |
674,736
-703
| -0.1% | -$18.2K | 0.09% | 175 |
|
2022
Q4 | $16M | Sell |
675,439
-17,930
| -3% | -$424K | 0.09% | 169 |
|
2022
Q3 | $17.6M | Buy |
693,369
+341,471
| +97% | +$8.66M | 0.12% | 137 |
|
2022
Q2 | $11.7M | Buy |
351,898
+316,492
| +894% | +$10.5M | 0.07% | 186 |
|
2022
Q1 | $2.55M | Buy |
+35,406
| New | +$2.55M | 0.01% | 448 |
|